Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Challenge-Stan

I would think it would have the opposite of the intended effect and there will surely be a net short term and long term lowering of the share price as potential investors would not touch such an investment with the proverbial ten foot pole.

What potential investors? You mean penny lottery players? I wouldn't call that investing. And right now, that's the realm PTSC is in and that's who's "investing."

While I don't think there is any chance of a successful shareholder lawsuit, I also don't think that any posts on Agora cause "net short term and long term lowering of the share price." The reality of the situation does a good enough job of that and is the primary driver here. Not sabre rattling about shareholder suits, which happens every single time any group of shareholders is unhappy with any given stock (just google any M&A - try 3par or IBM/Netezza for recent examples - even those with huge premiums for shareholders).

Share
New Message
Please login to post a reply